ORCID as entered in ROS

Select Publications
2025, 'The CD123 antibody–drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia', Hemasphere, 9, pp. e70063, http://dx.doi.org/10.1002/hem3.70063
,2024, 'TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells', Nature Communications, 15, pp. 7360, http://dx.doi.org/10.1038/s41467-024-51646-6
,2024, 'An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia', International Journal of Biological Macromolecules, 254, pp. 127596, http://dx.doi.org/10.1016/j.ijbiomac.2023.127596
,2021, 'A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia', International Journal of Biological Macromolecules, 190, pp. 214 - 223, http://dx.doi.org/10.1016/j.ijbiomac.2021.08.194
,2016, 'Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation', EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 88, pp. 91 - 100, http://dx.doi.org/10.1016/j.ejps.2016.04.004
,